Women In Bio (WIB) recently held its 2012 annual dinner at the Omni Shoreham Hotel in Washington D.C., and I was lucky enough to be invited. By  Rob Wright

I recently had the opportunity to attend two different events — the Society of Toxicology ToxExpo (SOT) and the Drug, Chemical, and Associated Technologies Week (DCAT). By  Rob Wright

The annual Partnerships in Clinical Trials event took place March 4 to 7 in Orlando, FL. It kicked off on Sunday with a Women’s Clinical Leadership Forum. As I was unable to attend this part of the conference I sought insight from those who did. By  Rob Wright

February marked the three-year anniversary of the first issue of Life Science Leader. So what, you say? Well, to the rest of the team and me, it’s a big deal. I doubt a lot of people in the industry thought we would last this long.

Last year I attended the Healthcare Businesswomen’s Association (HBA) Woman of The Year (WOTY) Annual Luncheon in New York City. I was so impressed with the caliber of people involved with this organization as well as the size and scope of the WOTY event.

Pharmaceutical and biotech companies are looking to emerging markets as the next frontier for drug development, discovery, and perhaps, the next breakthrough. By Rob Wright, Life Science Leader magazine

InformexUSA started out as a show with strictly tabletop exhibits. Twenty-eight years later, this event features nearly 500 exhibitors and nearly 4,000 attendees all focused on the global chemical market. By  Rob Wright

I recently spoke with someone who signed a cooperative R&D agreement with a military organization. Getting the federal government to put their vast resources behind developing your drug may seem like a no-brainer. By  Rob Wright

I recently posed this very question to Brian O’Callaghan, president and CEO of biotech company Sangart.